SEC Company Response from Traws Pharma, Inc. (TRAW) (CIK 0001130598) (TRAW) — May 17, 2019
Traws Pharma, Inc. (TRAW) (CIK 0001130598)
Date: May 17, 2019 · CIK: 0001130598 · Accession: 0001104659-19-030327
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-230744
Letter
Onconova Therapeutics, Inc.
375 Pheasant Run
Newtown, PA 18954
May 17, 2019
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention:
Tonya Aldave
Re:
Onconova Therapeutics, Inc.
Registration Statement on Form S-3
Filed April 5, 2019
File No. 333-230744
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Onconova Therapeutics, Inc. (the “Company”) hereby requests acceleration of the effective date of the above referenced registration statement, as amended, so that such registration statement may become effective at 4:00 p.m. (Washington, D.C. time) on May 21, 2019, or as soon as practicable thereafter.
ONCONOVA THERAPEUTICS, INC.
By:
/s/ MARK GUERIN
Name:
Mark Guerin
Title:
Chief Financial Officer
Show Raw Text
CORRESP 1 filename1.htm Onconova Therapeutics, Inc. 375 Pheasant Run Newtown, PA 18954 May 17, 2019 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Tonya Aldave Re: Onconova Therapeutics, Inc. Registration Statement on Form S-3 Filed April 5, 2019 File No. 333-230744 Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Onconova Therapeutics, Inc. (the “Company”) hereby requests acceleration of the effective date of the above referenced registration statement, as amended, so that such registration statement may become effective at 4:00 p.m. (Washington, D.C. time) on May 21, 2019, or as soon as practicable thereafter. ONCONOVA THERAPEUTICS, INC. By: /s/ MARK GUERIN Name: Mark Guerin Title: Chief Financial Officer